MSGR
Direxion mRNA ETF
MSGR
MSGR
Delisted
MSGR was delisted on the 21st of April, 2023.
1 hedge funds and large institutions have $323K invested in Direxion mRNA ETF in 2022 Q4 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
1
Holders Change
-2
Holders Change %
-66.67%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
Top Sellers
| 1 |
UBS Group
Zurich,
Switzerland
|
-$363K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$339K |
| 3 |
Citigroup
New York
|
-$17.6K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Citigroup
New York
| $323K | -$17.6K | -1,236 | -5% |
|
|
2
UBS Group
Zurich,
Switzerland
| – | -$363K | -26,810 | Closed |
|
|
3
Bank of America
Charlotte,
North Carolina
| – | -$339K | -25,000 | Closed |
|